Lefamulin for treating community-acquired bacterial pneumonia in adult patients aged < 65 years.
暂无分享，去创建一个
[1] S. Paukner,et al. Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial. , 2019, JAMA.
[2] T. File,et al. Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.